Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Robotic Anterior Resection for Rectal Cancer Laparoscopic

Age range

55 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, 225001, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.

Exclusion criteria

patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

Treatment and study plan

Robotic surgery

Procedure

robotic surgery

Laparoscopic surgery

Procedure

laparoscopic surgery

Primary outcomes

postoperative recurrence rate

Time frame: 2018-2024

postoperative recurrence rate

Sponsors and collaborators

Lead sponsor

Daorong Wang

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2022
Study completion: 2024
First posted: May 2, 2024
Registry last updated: May 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed